Colorado regents give alumna top honor

The University of Colorado Board of Regents has named Dr. Kathryn Bloch Horwitz its 2004 distinguished professor, the highest honor it can bestow.
Dr. Horwitz, professor at the University of Colorado Health Sciences Center and a 1975 graduate of UT Southwestern, was honored for her landmark research in breast cancer that has benefited women around the world.
"In her 25-year career at the CU-Health Sciences Center, Dr. Horwitz has become a world leader in molecular, cellular and tumor biology," said Dr. James Shore, chancellor of the University of Colorado at Denver and the CU-Health Sciences Center. "We are pleased to have her recognized for her research into the role of women's hormones in the development, diagnosis and treatment of breast cancer."
Dr. Horwitz was the first to report that certain breast cancers contain receptors for the hormone progesterone. This breakthrough discovery, among others, led to a shift in the assessment of tumor biopsies, which, worldwide, now include assays for estrogen and progesterone receptors to indicate if a tumor is hormone-responsive. Her work has contributed to the concept of "fingerprinting" a tumor to allow precisely targeted therapies.
Fewer than 30 University of Colorado faculty members hold the title of distinguished professor.
Among Dr. Horwitz's numerous honors are the presidency of the 10,000-member Endocrine Society, election as a Fellow of the American Association for the Advancement of Science and appointment to the President's Cancer Panel's Special Commission on Breast Cancer.
Dr. Horwitz received her Ph.D. in physiology from Southwestern Graduate School of Biomedical Sciences.